Colorado Clinical and Translational Sciences Institute: UL1 Diversity KL2 Supplement
科罗拉多临床和转化科学研究所:UL1 多样性 KL2 补充材料
基本信息
- 批准号:10288971
- 负责人:
- 金额:$ 14.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAddressAffectAfrican AmericanAmputationAntihypertensive AgentsAtlasesAwardBehaviorBeliefBiomedical ResearchCOVID-19COVID-19 patientCaringChildClinicalClinical SciencesCollaborationsColoradoCommunicationCommunitiesComputer softwareDataDevelopmentDiagnosisDiseaseDisease ManagementDrug PrescriptionsElderlyEnsureEnvironmentEthnic OriginFacultyFeedbackFosteringFundingFutureGoalsGrantGrant ReviewGuidelinesHealthHealth Services AccessibilityHealth systemHealthcareHealthcare SystemsHispanic AmericansHispanicsHomeHospitalsIndividualInformaticsInfrastructureInstitutesInterdisciplinary StudyInterventionInterviewK-Series Research Career ProgramsKnowledgeLearningLower ExtremityMeasuresMedicalMedical centerMentorsMethodologyMethodsMinorityNCI Scholars ProgramNot Hispanic or LatinoNursery SchoolsNursing FacultyOutcomeParentsPatient CarePatient RecruitmentsPatient-Focused OutcomesPatientsPerceptionPeripheral arterial diseasePharmaceutical PreparationsPhasePopulationPositioning AttributePreventive treatmentPrincipal InvestigatorProceduresProcessProgram DevelopmentProgram ReviewsProtocols documentationProviderPublic HealthRaceRare DiseasesRecommendationResearchResearch PersonnelResearch ProposalsResearch TrainingResourcesRiskRisk FactorsRoleSafetyScienceSelf ManagementServicesSpecial PopulationSurveysTestingTrainingTraining SupportTraining and EducationTranslational ResearchTranslationsUnderserved PopulationUnited States National Institutes of HealthUniversitiesWorkadherence rateadverse outcomecare deliverycare outcomescareercareer developmentcommunity engagementcommunity organizationsdesigndisparity eliminationeffectiveness implementation studyeffectiveness implementation trialethnic minority populationevidence baseexperienceformative assessmenthealth care availabilityhealth care deliveryhealth care disparityhealth care settingshealth differencehealth disparityhealth inequalitiesimplicit biasimprovedinnovationmedical specialtiesmedication compliancemeetingsmembermodifiable behaviornovelpandemic diseasepatient populationpeerprogramsracial and ethnicracial and ethnic disparitiesracial differenceresearch and developmentrisk perceptionsafety netsocial health determinantstherapy designtherapy developmenttranslational scientisttreatment disparity
项目摘要
Principal Investigator (Last, first, middle): Sokol, Ronald (Diversity Candidate: McNeal, Demetria, M)
SUMMARY
Abstract of NCATS-Funded UL1 Project
Funded by NIH in 2008, 2013 and 2018 the Colorado Clinical and Translational Sciences Institute (CCTSI) at
the University of Colorado Anschutz Medical Campus (CUAMC) has transformed and improved the biomedical;
research and training enterprise in the Colorado region and accelerated and catalyzed the translation of
discoveries into improved patient care and public health. The CCTSI, a partnership of CUAMC, CU Boulder,
Colorado State University, six hospitals and 20 community organizations, has established new infrastructure,
streamlined processes and expanded existing resources and services for investigators and stakeholders;
tripled the number of training and education programs supporting development of a translational workforce;
promoted team science and interdisciplinary research; established an extensive community engagement
program; created an academic home for clinical & translational scientists and trainees; and actively engaged in
CTSA network activities. CCTSI has five overall strategic goals:
Goal 1: Develop, educate and sustain a diverse translational science workforce to ensure the highest research
innovation, quality and safety.
Goal 2: Create a translational research environment in which team science and local and national collaboration
are facilitated, supported and valued.
Goal 3: Engage local and national communities and stakeholders in all phases of the translational research
process.
Goal 4: Create novel methodologies and resources to support and integrate research in special populations,
including children, the elderly, the underserved and those with rare diseases.
Goal 5: Further innovate and streamline our processes and enhance our informatics capacity for research
start-up, implementation and oversight to promote quality, efficiency, & safety of our research and our active
participation in the national CTSA Trial Innovation Network.
Dr. McNeal's proposal capitalizes on CCTSI's goals one and four and their accompanying resources in the
following ways. First, to support attainment of CCTSI goal 1, the CCTSI has established new programs and
offers resources designed to support the development of early stage career faculty. Existing programs and
resources create the ideal environment for Dr. McNeal, a junior and minority faculty member, to advance and
thrive as an independent scholar. To prepare for this submission, Dr. McNeal has already participated in one
CCTSI sponsored program (CCTSI Research Studio) in which a team of interdisciplinary senior scholars
reviewed this project proposal and provided feedback to further refine the research question and methodology.
Dr. McNeal has been competitively selected to participate in two research and career development programs:
The National Institutes of Health Programs to Increase Diversity Among Individuals Engaged in Health-Related
Research (PRIDE) and the CCTSI-sponsored Clinical Faculty Scholars Program. Additionally, Dr. McNeal has
completed two Atlas.ti courses to learn software management for qualitative data. To support learning
opportunities identified in the Mentoring Plan (see figure 2), Dr. McNeal will have access to both coursework
and hands on experiences over the course of the award period. Specific CCTSI training includes course work
through the Clinical Sciences Graduate Program, the KL2 career in progress monthly meetings, the Pre-K
grant review program and the Research Studio. Additional CCTSI trainings that Dr. McNeal will use include
Regulatory Knowledge and Support, Protocol Submission and Recruiting Participants (see table 3). Second, in
alignment with CCTSI goal 4, the study has an explicit focus on underserved populations. Dr. McNeal is
investigating Black and Hispanic American populations. The project will identify underlying clinician and
patient related factors that contribute to health disparities in outcomes and health inequities in care delivery
among African American and Hispanic patients with peripheral artery disease (PAD). This is an important and
novel project that is the first step in addressing health disparities and fits very well within the Parent U1 grant
and the functions of the CCTSI.
主要研究者(最后、第一、中间):索科尔、罗纳德(多样性候选人:McNeal、Demetria、M)
总结
NCATS-Funded UL1项目摘要
由NIH在2008年,2013年和2018年资助的科罗拉多临床和转化科学研究所(CCTSI),
科罗拉多大学安舒茨医学院(CUAMC)已经改变和改善了生物医学;
研究和培训企业在科罗拉多地区,并加速和催化翻译
改善病人护理和公共卫生的新发现。CCTSI是CUAMC,CU Boulder,
科罗拉多州立大学、6家医院和20个社区组织,建立了新的基础设施,
简化程序,扩大现有资源和为调查人员和利益攸关方提供的服务;
将支持翻译工作队伍发展的培训和教育项目数量增加两倍;
促进团队科学和跨学科研究;建立广泛的社区参与
计划;为临床和转化科学家和学员创建了一个学术之家;并积极参与
CTSA网络活动。CTSI有五个总体战略目标:
目标1:发展、教育和维持多样化的转化科学工作队伍,以确保最高水平的研究
创新、质量和安全。
目标2:创造一个转化研究的环境,在其中团队科学和地方和国家合作
得到促进、支持和重视。
目标3:让地方和国家社区及利益攸关方参与转化研究的所有阶段
过程
目标4:创造新的方法和资源,以支持和整合对特殊人群的研究,
包括儿童、老年人、得不到充分服务的人和患有罕见疾病的人。
目标5:进一步创新和精简我们的程序,加强我们的研究信息能力
启动,实施和监督,以提高质量,效率,我们的研究和我们的积极安全
参与国家CTSA试验创新网络。
博士McNeal的提案利用了CCTSI的目标一和四及其在
遵循方式。首先,为了支持实现CCTSI目标1,CCTSI制定了新的计划,
提供旨在支持早期职业教师发展的资源。现有的程序和
资源为麦克尼尔博士,一个初级和少数民族教师创造了理想的环境,以促进和
作为一个独立的学者。为了准备这次提交,McNeal博士已经参加了一个
CCTSI赞助的项目(CCTSI研究工作室)中,跨学科的高级学者团队
审查了该项目提案并提供反馈以进一步完善研究问题和方法。
博士麦克尼尔已竞争性地选择参加两个研究和职业发展计划:
美国国立卫生研究院计划增加与健康相关的个人之间的多样性
研究(PRIDE)和CCTSI赞助的临床教师学者计划。此外,McNeal博士
完成了两个Atlas. ti课程,学习质量数据软件管理。来支持学习
机会中确定的指导计划(见图2),麦克尼尔博士将有机会获得这两门课程
并在获奖期间亲身体验。具体的CCTSI培训包括课程工作
通过临床科学研究生课程,KL2职业发展每月会议,Pre-K
资助审查计划和研究工作室。McNeal博士将使用的其他CCTSI培训包括
法规知识和支持、方案提交和招募参与者(见表3)。二是
该研究与《儿童与社会服务倡议》的目标4相一致,明确关注得不到充分服务的人口。麦克尼尔医生
调查黑人和西班牙裔美国人该项目将确定潜在的临床医生和
与患者相关的因素,导致结果中的健康差异和护理提供中的健康不平等
非裔美国人和西班牙裔外周动脉疾病(PAD)患者。这是一个重要的,
一个新颖的项目,这是解决健康差距的第一步,非常适合父母U1赠款
以及CCTSI的功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD J. SOKOL其他文献
RONALD J. SOKOL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD J. SOKOL', 18)}}的其他基金
Colorado Clinical and Transational Sciences Institute
科罗拉多临床和转化科学研究所
- 批准号:
9926512 - 财政年份:2019
- 资助金额:
$ 14.58万 - 项目类别:
Colorado Clinical and Transational Sciences Institute
科罗拉多临床和转化科学研究所
- 批准号:
9926131 - 财政年份:2018
- 资助金额:
$ 14.58万 - 项目类别:
Colorado Clinical and Transational Sciences Institute
科罗拉多临床和转化科学研究所
- 批准号:
10402976 - 财政年份:2018
- 资助金额:
$ 14.58万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 14.58万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 14.58万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 14.58万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 14.58万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 14.58万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 14.58万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 14.58万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 14.58万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 14.58万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 14.58万 - 项目类别:
Research Grant














{{item.name}}会员




